Truist analyst John Lee initiated coverage of Solid Biosciences (SLDB) with a Buy rating and $16 price target
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLDB:
- Closing Bell Movers: Cal-Maine Foods up 5% on Q2 results
- Solid Biosciences gains 12% to $4.40 on FDA clearance of SGT-212 IND
- Solid Biosciences announces FDA clearance of SGT-212 IND application
- Solid Biosciences reports inducement grants under Nasdaq listing rule
- Closing Bell Movers: International Seaways up 8% on S&P600 inclusion